Heart Disease Clinical Trials in Denver

Showing 281-300 of 365 trials

Improving Prevention of Heart Disease in Latinos

NCT00101530

The purpose of the study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities. Specifically, it seeks to improve the primary prevention of CVD in Hispanics.

Cardiovascular DiseasesHeart DiseasesHypertension+1 more

University of Colorado, Denver179 participantsStarted Sep 2004

Denver, Colorado, United States

COMPLETED< 1 mile

TAXUS Libertē Post Approval Study

NCT00997503

The TAXUS Libertē Post-Approval Study is an FDA-mandated prospective, multi-center study designed to collect real-world safety and clinical outcomes in approximately 4,200 patients receiving one or more TAXUS Liberté Paclitaxel-Eluting Stents and prasugrel as part of a dual antiplatelet therapy (DAPT) drug regimen. This study will also contribute patient data to an FDA-requested and industry-sponsored research study that will evaluate the optimal duration of dual antiplatelet therapy (DAPT Study).

Coronary Artery Disease

Boston Scientific Corporation4,199 participantsStarted Dec 2009

Mesa, Arizona, United States • Jonesboro, Arkansas, United States • Jonesboro, Arkansas, United States +79 more locations

Improving Prevention of Heart Disease in Latinos

TAXUS Libertē Post Approval Study

Heart Disease Trials in Other Cities

Does Prophylactic Coronary Artery Revascularization for High Risk Patients Reduce Long-term Risk of Mortality

Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function

A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease

Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients

GORE Flow Reversal System and GORE Embolic Filter Extension Study

Niacin Plus Statin to Prevent Vascular Events

A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

Efficacy and Safety Study of ISIS 301012 (Mipomersen) as Add-on in Familial Hypercholesterolemic Patients With Coronary Artery Disease

Feasibility Study of BMAC Enhanced CABG

Randomized, Double-Blind, Placebo Controlled Study of the Short Term Clinical Effects of Tolvaptan in Patients Hospitalized for Worsening Heart Failure With Challenging Volume Management

Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure

Radial Artery Access With Ultrasound Trial

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement

Sensor Optimization of Cardiac Resynchronization Therapy Response

Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes

RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care

Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina

Other Conditions in Denver